Journal Article

Human Interindividual Variation in Lymphocyte UDP-Glucuronosyltransferases as a Determinant of <i>In Vitro</i> Benzo[a]pyrene Covalent Binding and Cytotoxicity

Zhuohan Hu and Peter G. Wells

in Toxicological Sciences

Volume 78, issue 1, pages 32-40
Published in print March 2004 | ISSN: 1096-6080
Published online March 2004 | e-ISSN: 1096-0929 | DOI: http://dx.doi.org/10.1093/toxsci/kfh010
Human Interindividual Variation in Lymphocyte UDP-Glucuronosyltransferases as a Determinant of In Vitro Benzo[a]pyrene Covalent Binding and Cytotoxicity

More Like This

Show all results sharing these subjects:

  • Medical Toxicology
  • Toxicology (Non-medical)

GO

Show Summary Details

Preview

UDP-glucuronosyltransterases (UGTs) catalyse the glucuronidation and elimination of most xenobiotics and, thereby, may prevent their alternative bioactivation to carcinogenic and teratogenic reactive intermediates. Previous studies have shown that glucuronidation, bioactivation, and covalent binding of the carcinogen/teratogen benzo[a]pyrene (BP) in rat lymphocytes accurately reflected those processes in hepatic microsomes from the same animals. Accordingly, lymphocytes from 12 normal human volunteers were incubated with BP metabolites to determine UGT variability and its potential toxicological relevance. Over 200-fold interindividual variability was observed in both the glucuronidation and covalent binding of BP metabolites, with decreasing total glucuronidation among subjects correlating with a decreased UGT-modulated reduction in covalent binding (R2 = 0.8272, p < 0.01) and, in six subjects, enhanced cytotoxicity (r = −0.9338, p < 0.001). Decreased glucuronidation of both BP diols (r = −0.9106, p < 0.001) and BP diones (r = −0.9625, p < 0.005), but not BP monophenols, correlated with enhanced cytotoxicity. These results provide the first evidence for substantial interindividual variability in UGT activities for BP metabolites among the normal population and suggest that UGT-deficient individuals may be at increased risk from the reactive intermediate-mediated effects of BP and related xenobiotics.

Keywords: glucuronidation; benzo[a]pyrene; cancer; birth defects; bioactivation; reactive intermediates

Journal Article.  6064 words.  Illustrated.

Subjects: Medical Toxicology ; Toxicology (Non-medical)

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.